1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women;Lancet,1992
2. Tamoxifen for early breast cancer: an overview of the randomised trials;Lancet,1998
3. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh;Lancet,1987
4. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values;Rose;Lancet,1985
5. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation;Lancet,1983